Alliance for Multispecialty Research, LLC. | Newton, KS

Research site

(Unclaimed)

Location

700 Medical Center Dr Suite 110, Newton, Kansas, United States of America

Site insights

Top conditions

Top treatments

ABP-671

LY3502970

BW-00112

Linaclotide

MK-0616-037

Semaglutide

Orforglipron

Systane

Retatrutide

Cholesterol

Parent organization

This site is a part of Alliance for Multispecialty Research, LLC.

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 37 total trials

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

Researchers designed a study medicine called enlicitide to lower low-density lipoprotein cholesterol (LDL-C). In this study, researchers want to lear...

Active, not recruiting

Hyperlipidemia

Drug: Placebo for Rosuvastatin

Drug: Enlicitide

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight....

Enrolling

Obesity

Type 2 Diabetes

Drug: Cagrisema

Drug: Semaglutide

A Study in Patients With Mixed Dyslipidemia

A Phase 2 in Patients With Mixed Dyslipidemia

Active, not recruiting

Mixed Dyslipidemia

Drug: BW-00112

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06) (ANCHOR)

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000...

Active, not recruiting

Influenza

Combination Product: MK-1406

Combination Product: Placebo

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination

The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunoge...

Active, not recruiting

Chikungunya Virus Infection

Biological: CHIKV VLP vaccine booster

Biological: Placebo booster

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

The purpose of this clinical study is to look at the safety and tolerability of switching from semaglutide to CagriSema, for participants who have ty...

Not yet enrolling

Diabetes Mellitus, Type 2

Drug: CagriSema

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine (UBRO MM)

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing,...

Active, not recruiting

Migraine

Drug: Ubrogepant

Drug: Placebo for Ubrogepant

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Active, not recruiting

Atherosclerotic Cardiovascular Disease (ASCVD)

Chronic Kidney Disease (CKD)

Drug: Retatrutide

Drug: Placebo